XML 48 R37.htm IDEA: XBRL DOCUMENT v3.4.0.3
SEGMENT INFORMATION (Tables)
6 Months Ended
Apr. 30, 2016
Segment Reporting [Abstract]  
Segment Profitability and Segment Assets
The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Three months ended April 30, 2016:
 

 
 

 
 

 
 

Total net revenue
$
495

 
$
178

 
$
346

 
$
1,019

Segment income from operations
$
94

 
$
27

 
$
74

 
$
195

Three months ended April 30, 2015:
 

 
 

 
 

 
 

Total net revenue
$
473

 
$
169

 
$
321

 
$
963

Segment income from operations
$
75

 
$
25

 
$
69

 
$
169

 
 
 
 
 
 
 
 
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Six months ended April 30, 2016:
 

 
 

 
 

 
 

Total net revenue
$
1,021

 
$
336

 
$
690

 
$
2,047

Segment income from operations
$
208

 
$
42

 
$
150

 
$
400

Six months ended April 30, 2015:
 

 
 

 
 

 
 

Total net revenue
$
1,020

 
$
317

 
$
652

 
$
1,989

Segment income from operations
$
182

 
$
26

 
$
137

 
$
345

The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, including deferred tax assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.  
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Assets:
 

 
 

 
 

 
 

As of April 30, 2016
$
1,699

 
$
2,052

 
$
1,062

 
$
4,813

As of October 31, 2015
$
1,539

 
$
2,027

 
$
1,008

 
$
4,574


 
Reconciliation of segment results to total enterprise results
The following table reconciles reportable segments’ income from operations to Agilent’s total enterprise income before taxes:
 
 
Three Months Ended
 
Six Months Ended
 
April 30,
 
April 30,
 
2016
 
2015
 
2016
 
2015
 
(in millions)
Total reportable segments’ income from operations
$
195

 
$
169

 
$
400

 
$
345

Acceleration of share-based compensation related to workforce reduction

 
(1
)
 

 
(2
)
Transformational initiatives
(10
)
 
(17
)
 
(21
)
 
(29
)
Amortization of intangibles
(40
)
 
(38
)
 
(83
)
 
(81
)
Acquisition and integration costs
(12
)
 
(1
)
 
(17
)
 
(2
)
Business exit and divestiture costs (primarily our NMR business)
(1
)
 
(8
)
 
(6
)
 
(11
)
Pension curtailment gain

 

 
16

 

Other
(1
)
 
3

 
(3
)
 
2

Interest income
3

 
2

 
5

 
4

Interest expense
(18
)
 
(17
)
 
(36
)
 
(33
)
Other income (expense), net
1

 
4

 
4

 
16

Income from continuing operations before taxes, as reported
$
117

 
$
96

 
$
259

 
$
209